bifa必发
Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2023.03.30
bifa必发：关于使用自有资金购买理财产品及进行现金管理的公告
2023.03.30
bifa必发：独立董事关于第五届董事会第二十五次会议相关事项之事前认可意见
2023.03.30
bifa必发：独立董事提名人声明（易铭）
2023.03.30
bifa必发：独立董事候选人声明（易铭）
2023.03.30
bifa必发：关于开展以套期保值为目的的外汇衍生品交易的可行性分析报告
2023.03.30
bifa必发：2022年度监事会工作报告
2023.03.30
bifa必发：独立董事提名人声明（吕川）
2023.03.30
bifa必发：独立董事候选人声明（吕川）
2023.03.30
bifa必发：独立董事对担保等事项的独立意见
2023.03.30
bifa必发：2022年度财务决算报告
第一页
上一页
11
12
13
14
15
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright © 2024 Hepalink Group. All Rights Reserved.
